Nomi Health Expands Community Testing to Include All-in-One Test for Influenza, COVID
Nomi Health is expanding its testing offerings to include influenzas A and B at its Utah COVID-19 testing sites.
Category: Flu & Respiratory Infections
Flu & Respiratory Infections
Latest
Flu & Respiratory Infections
Latest
Study Discovers High Prevalence of COVID & Flu Co-Infections
Researchers have discovered a high prevalence of COVID co-infections in central Missouri during the 2021-2022 flu season.
Flu & Respiratory Infections
Latest
Influenza Home Tests as Accurate as Clinical Rapid Testing
Home-based, self-administered tests for influenza are comparable in accuracy to rapid diagnostic tests in clinical settings.
Cold and Flu Viruses May Return With a Vengeance
The cold and flu viruses that many have avoided while staying at home and social distancing during the COVID-19 pandemic will likely run rampant again as masks come off and schools reopen, reports STAT News.
Read More
GT Molecular Launches PCR Tests for COVID-19 Delta Variant, Influenza A/B
GT Molecular has started shipping its sensitive PCR tests to monitor the coronavirus Delta variant (B.1.617.2) as well as testing and PCR kits for the detection of Influenza A and B.
Read More
Testing Tool Can Quickly Distinguish Between Viral and Bacterial Infections
Researchers showed that their testing technology can accurately distinguish between a viral and a bacterial infection for respiratory illness and the test provided results in under an hour.
Read More
ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for Covid-19, Other Viruses
Testing integrates the Spectrum Solutions saliva self-collection system with a new, advanced multiplex qPCR platform for the simultaneous RNA detection of covid-19 and its viral mutations, as well as Influenza A, B, and more.
Read More
The Pandemic Broke the Flu
This winter has been an extraordinarily quiet flu season. Scientists aren’t sure the silence will last, according to a report in The Atlantic.
Read More
QuantuMDx Scales Up to Mass Manufacture Q-POC
QuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read More
Point of Care Testing Can Improve Influenza Detection, Treatment
New research has shown that implementing point-of-care testing in hospitals to diagnose influenza can lead to better treatment and faster recovery for patients.
Read More
EuroImmun Launches PCR Test to Differentiate Covid-19 and Flu
The new EuroRealTime test allows fast detection and differentiation of genetic material from SARS-CoV-2, influenza virus type A, and influenza virus type B using throat swab samples of patients with acute symptoms.
Read More
PerkinElmer Receives CE Mark for Multianalyte Respiratory Panel Including Covid-19
The PKamp Respiratory SARS-CoV-2 RT-PCR Panel enables differential diagnosis between covid-19, flu, and RSV infections.
Read More
FDA Issues New Enforcement Policy for Modifications to FDA-Cleared Molecular Influenza and RSV Tests
The FDA has issued and immediately implemented a new guidance: Enforcement Policy for Modifications to FDA-Cleared Molecular Influenza and RSV Tests During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency.
Read More
FDA EUA for Quidel’s Rapid Antigen “ABC Test” for Influenza A and B and Covid-19
The Sofia 2 Flu + SARS Antigen FIA point-of-care test delivers three results from one sample in 15 minutes.
Read More
Simplexa Flu A/B & RSV Direct Gen II Assay Gets FDA Clearance
The Simplexa Flu A/B & RSV Direct Gen II assay can be run alone or alongside the Simplexa Covid-19 Direct kit.
Read More
Exact Diagnostics Launches Multiplex Control for Use with Molecular Respiratory Panel Assays
Routine use of the positive run control enables laboratories to meet their individualized quality control goals, including evaluation of reagent lot changes and new shipments.
Read More
FDA Clears Applied BioCode Respiratory Pathogen Panel
The panel tests nasopharyngeal swabs for the most common respiratory viruses and bacteria.
Read More
FDA Clears Unyvero LRT Panel for Use with Bronchoalveolar Lavage Specimens
The panel test detects Pneumocystis jirovecii in addition to a broad spectrum of clinically relevant bacterial pathogens and antibiotic-resistance markers associated with pneumonia.
Read More